Brief Information of the Cell Line and Protein
Cell Line ID: CL000252 , WM266-4
Synonyms
WM-266-4
WM 266-4
WM-2664
WM2664
WM 2664
WM266
WM-266-mel
WM266mel
WC00097
Category Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_2765
Protein ID: PT01766 , Sphingosine kinase 1
Gene Name SPHK1
Organism Homo sapiens, Human
Protein Classification Enzyme
Uniprot ID Q9NYA1
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000252  Protein ID: PT01766
 
Compound ID Compound Name Compound Formula
CP0186782
(2R,4S)-1-[2-[4-[[4-(2-chlorophenyl)-1,3-thiazol-2-yl]amino]phenyl]ethyl]-2-(hydroxymethyl)piperidin-4-ol
   Show/Hide
C23H26ClN3O2S
 1
1
EC50 = 80 nM
   TI
   LI
   LO
   TS
CP0067907
(2R,4S)-2-(hydroxymethyl)-1-[2-[4-[[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]amino]phenyl]ethyl]piperidin-4-ol
   Show/Hide
C24H26F3N3O2S
 1
1
EC50 = 90 nM
   TI
   LI
   LO
   TS
CP0304537
(2R,4S)-2-(hydroxymethyl)-1-[2-[4-[[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]amino]phenyl]ethyl]piperidin-4-ol
   Show/Hide
C24H29N3O3S
 1
1
EC50 = 100 nM
   TI
   LI
   LO
   TS
CP0215983
(2R,4S)-2-(hydroxymethyl)-1-[2-[4-[[4-(3-methylphenyl)-1,3-thiazol-2-yl]amino]phenyl]ethyl]piperidin-4-ol
   Show/Hide
C24H29N3O2S
 1
1
EC50 = 110 nM
   TI
   LI
   LO
   TS
CP0100910
(2R,4S)-2-(hydroxymethyl)-1-[2-[4-[[4-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]amino]phenyl]ethyl]piperidin-4-ol
   Show/Hide
C24H26F3N3O2S
 1
1
EC50 = 120 nM
   TI
   LI
   LO
   TS
CP0220533
(2R,4S)-1-[2-[4-[[4-[2-fluoro-4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]amino]phenyl]ethyl]-2-(hydroxymethyl)piperidin-4-ol
   Show/Hide
C24H25F4N3O2S
 1
1
EC50 = 120 nM
   TI
   LI
   LO
   TS
CP0078863
(2R,4S)-1-[2-[4-[[4-(4-chlorophenyl)-1,3-thiazol-2-yl]amino]phenyl]ethyl]-2-(hydroxymethyl)piperidin-4-ol
   Show/Hide
C23H26ClN3O2S
 1
1
EC50 = 130 nM
   TI
   LI
   LO
   TS
CP0233130
(2R,4S)-1-[2-[4-[[4-(2-fluorophenyl)-1,3-thiazol-2-yl]amino]phenyl]ethyl]-2-(hydroxymethyl)piperidin-4-ol
   Show/Hide
C23H26FN3O2S
 1
1
EC50 = 130 nM
   TI
   LI
   LO
   TS
CP0199269
(2R,4S)-1-[2-[4-[[4-[2-fluoro-3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]amino]phenyl]ethyl]-2-(hydroxymethyl)piperidin-4-ol
   Show/Hide
C24H25F4N3O2S
 1
1
EC50 = 250 nM
   TI
   LI
   LO
   TS
CP0215985
(2R,4S)-1-[2-[4-[(4-cyclohexyl-1,3-thiazol-2-yl)amino]phenyl]ethyl]-2-(hydroxymethyl)piperidin-4-ol
   Show/Hide
C23H33N3O2S
 1
1
EC50 = 280 nM
   TI
   LI
   LO
   TS
CP0176540
(2R,4S)-2-(hydroxymethyl)-1-[2-[4-[(4-phenyl-1,3-thiazol-2-yl)amino]phenyl]ethyl]piperidin-4-ol
   Show/Hide
C23H27N3O2S
 1
1
EC50 = 310 nM
   TI
   LI
   LO
   TS
CP0176546
(2R,4S)-1-[2-[4-[[4-(2,4-dichlorophenyl)-1,3-thiazol-2-yl]amino]phenyl]ethyl]-2-(hydroxymethyl)piperidin-4-ol
   Show/Hide
C23H25Cl2N3O2S
 1
1
EC50 = 360 nM
   TI
   LI
   LO
   TS
CP0186811
(2R,4S)-1-[2-[4-[(4-butyl-1,3-thiazol-2-yl)amino]phenyl]ethyl]-2-(hydroxymethyl)piperidin-4-ol
   Show/Hide
C21H31N3O2S
 1
1
EC50 = 370 nM
   TI
   LI
   LO
   TS
CP0176545
(2R,4S)-1-[2-[4-[[4-[2-fluoro-5-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]amino]phenyl]ethyl]-2-(hydroxymethyl)piperidin-4-ol
   Show/Hide
C24H25F4N3O2S
 1
1
EC50 = 390 nM
   TI
   LI
   LO
   TS
CP0248976
(2R,4S)-1-[2-[4-[(4-cyclopentyl-1,3-thiazol-2-yl)amino]phenyl]ethyl]-2-(hydroxymethyl)piperidin-4-ol
   Show/Hide
C22H31N3O2S
 1
1
EC50 = 850 nM
   TI
   LI
   LO
   TS
CP0225106
(2R,4S)-2-(hydroxymethyl)-1-[2-[4-[[4-(3-methoxyphenyl)-1,3-thiazol-2-yl]amino]phenyl]ethyl]piperidin-4-ol
   Show/Hide
C24H29N3O3S
 1
1
EC50 = 870 nM
   TI
   LI
   LO
   TS
CP0176542
(2R,4S)-1-[2-[4-[[4-(4-fluorophenyl)-1,3-thiazol-2-yl]amino]phenyl]ethyl]-2-(hydroxymethyl)piperidin-4-ol
   Show/Hide
C23H26FN3O2S
 1
1
EC50 = 1200 nM
   TI
   LI
   LO
   TS
CP0203703
(2R,4S)-1-[2-[4-[[4-(3-fluorophenyl)-1,3-thiazol-2-yl]amino]phenyl]ethyl]-2-(hydroxymethyl)piperidin-4-ol
   Show/Hide
C23H26FN3O2S
 1
1
EC50 = 1200 nM
   TI
   LI
   LO
   TS
CP0199268
(2R,4S)-1-[2-[4-[[4-(1-adamantyl)-1,3-thiazol-2-yl]amino]phenyl]ethyl]-2-(hydroxymethyl)piperidin-4-ol
   Show/Hide
C27H37N3O2S
 1
1
EC50 = 1900 nM
   TI
   LI
   LO
   TS